Literature DB >> 1577470

The French Canadian Tay-Sachs disease deletion mutation: identification of probable founders.

M De Braekeleer1, P Hechtman, E Andermann, F Kaplan.   

Abstract

Tay-Sachs disease (TSD) is an inherited neurodegenerative ganglioside storage disorder caused by deficiency of the hexosaminidase A enzyme. A deletion allele (FCD) at the HEXA locus has attained high frequency in the French Canadian population. The distribution of affected probands shows a likely center of diffusion for this mutation located in the Bas-St.-Laurent and Gaspésie regions of the province of Quebec. We have reconstructed the genealogies of 15 obligate carriers of the FCD allele to an average depth of 12 generations identifying 60 ancestors and 80 European founders common to all of them. The ancestral origins of the European founders show a significantly greater number of individuals born in the French provinces of Normandy and Perche than expected based on information regarding the origins of the 8,500 immigrants who settled the colony of New France during the French regime. We have identified common ancestors among the 10 who were born in Quebec who appear to be likely candidates for the origin of the FCD mutation. One such couple had 11 children, 5 of whom settled in regions of Quebec or New Brunswick that today have elevated heterozygote frequencies for the FCD. The five offspring are ancestors of all known carriers. By contrast, the absence of FCD alleles among TSD probands in France suggests that the mutation did not occur in a European founder.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577470     DOI: 10.1007/bf00207048

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

1.  A deletion involving Alu sequences in the beta-hexosaminidase alpha-chain gene of French Canadians with Tay-Sachs disease.

Authors:  R Myerowitz; N D Hogikyan
Journal:  J Biol Chem       Date:  1987-11-15       Impact factor: 5.157

2.  More than one mutant allele causes infantile Tay-Sachs disease in French-Canadians.

Authors:  P Hechtman; F Kaplan; J Bayleran; B Boulay; E Andermann; M de Braekeleer; S Melançon; M Lambert; M Potier; R Gagné
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

3.  Tay-Sachs disease in Quebec: evidence for a geographic aggregate in the French-Canadian population and identification of a new retardation syndrome with possible linkage to the Tay-Sachs gene.

Authors:  E Andermann; F Andermann; G Patry; R Lafontaine; G Geoffroy; C R Scriver; L Wolfe
Journal:  Trans Am Neurol Assoc       Date:  1973

4.  Founder effect in familial hyperchylomicronemia among French Canadians of Quebec.

Authors:  M De Braekeleer; C Dionne; C Gagné; P Julien; D Brun; M R Ven Murthy; P J Lupien
Journal:  Hum Hered       Date:  1991       Impact factor: 0.444

5.  Tay-Sachs disease: generalized absence of a beta-D-N-acetylhexosaminidase component.

Authors:  S Okada; J S O'Brien
Journal:  Science       Date:  1969-08-15       Impact factor: 47.728

6.  Genetic variants of Tay-Sachs disease: Tay-Sachs disease and Sandhoff's disease in French Canadians, juvenile Tay-Sachs disease in Lebanese Canadians, and a Tay-Sachs screening program in the French-Canadian population.

Authors:  E Andermann; C R Scriver; L S Wolfe; L Dansky; F Andermann
Journal:  Prog Clin Biol Res       Date:  1977

7.  Genetic epidemiology of hereditary tyrosinemia in Quebec and in Saguenay-Lac-St-Jean.

Authors:  M De Braekeleer; J Larochelle
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

8.  Different mutations in Ashkenazi Jewish and non-Jewish French Canadians with Tay-Sachs disease.

Authors:  R Myerowitz; N D Hogikyan
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728

9.  Allele-specific amplification of genomic DNA for detection of deletion mutations: identification of a French-Canadian Tay-Sachs mutation.

Authors:  F Kaplan; B Boulay; J Bayleran; P Hechtman
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

  9 in total
  6 in total

1.  Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.

Authors:  B R Akerman; M R Natowicz; M M Kaback; M Loyer; E Campeau; R A Gravel
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

2.  Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools.

Authors:  J J Mitchell; A Capua; C Clow; C R Scriver
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

3.  Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England.

Authors:  B Triggs-Raine; M Richard; N Wasel; E M Prence; M R Natowicz
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

4.  The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada.

Authors:  P Hechtman; B Boulay; M De Braekeleer; E Andermann; S Melançon; J Larochelle; C Prevost; F Kaplan
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

5.  Screening for Tay-Sachs disease carriers by full-exon sequencing with novel variant interpretation outperforms enzyme testing in a pan-ethnic cohort.

Authors:  Alana C Cecchi; Elizabeth S Vengoechea; Kristjan E Kaseniit; Melanie W Hardy; Laura A Kiger; Nikita Mehta; Imran S Haque; Krista Moyer; Patricia Z Page; Dale Muzzey; Karen A Grinzaid
Journal:  Mol Genet Genomic Med       Date:  2019-07-10       Impact factor: 2.183

6.  Tay-Sachs Carrier Screening by Enzyme and Molecular Analyses in the New York City Minority Population.

Authors:  Nikita Mehta; Gabriel A Lazarin; Erica Spiegel; Kathleen Berentsen; Kelly Brennan; Jessica Giordano; Imran S Haque; Ronald Wapner
Journal:  Genet Test Mol Biomarkers       Date:  2016-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.